Reprogenix is based in Hangzhou, China. It has raised $14M in total funding. Latest round: Series A.
Reprogenix funding overview
Reprogenix is based in Hangzhou, China. Reprogenix has raised $14M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in November 2025. The round record for Reprogenix runs through 2025; nothing later has been disclosed. Investors on record include CRHC Fund, Yuanbio Venture Capital, Fu Zhe Capital, Sinowisdom, Orient Renaissance Capital, Lotus Lake Capital and 3 others. 9 distinct backers are named across the disclosed rounds.
Reprogenix at a glance
Total raised
$14M
Latest round
Series A
Latest round date
November 2025
Headquarters
Hangzhou, China
Notable investors
CRHC Fund, Yuanbio Venture Capital, Fu Zhe Capital, Sinowisdom, Orient Renaissance Capital, Lotus Lake Capital, Yuhang State-Owned Capital Investment, GAGE Capital
Frequently asked about Reprogenix funding
How much has Reprogenix raised?
Reprogenix has raised $14M in total disclosed funding across the rounds on record.
Who has invested in Reprogenix?
CRHC Fund, Yuanbio Venture Capital, Fu Zhe Capital, Sinowisdom, Orient Renaissance Capital, Lotus Lake Capital are named among the investors backing Reprogenix.
What was the latest Reprogenix funding round?
The most recent disclosed round is a Series A, announced in November 2025.
Where is Reprogenix based?
Reprogenix is based in Hangzhou, China.
When did Reprogenix last raise?
The last disclosed Reprogenix round closed in November 2025 at Series A.
Totals shown for Reprogenix aggregate every disclosed round on file. To see how that compares, browse the companies in Hangzhou and the investors behind them below.
